The mTOR signalling pathway in human cancer.
作者： Helena Pópulo , José Manuel Lopes , Paula Soares
DOI: 10.3390/IJMS13021886
关键词:
摘要: … and downstream effectors, and the role of mTOR in cancer, mainly in melanoma. … mTOR signalling in cancer and reinforce the importance of considering mTOR targeting in cancer …
mdpi.com
sci-hub.se 参考文章(233)
Shile Huang, Peter J. Houghton, Resistance to Rapamycin: A Novel Anticancer Drug Cancer and Metastasis Reviews. ,vol. 20, pp. 69- 78 ,(2001) , 10.1023/A:1013167315885
Mary-Ann Bjornsti, Peter J Houghton, Lost in translation Cancer Cell. ,vol. 5, pp. 519- 523 ,(2004) , 10.1016/J.CCR.2004.05.027
Friedegund Meier, Birgit Schittek, Silke Busch, Claus Garbe, Keiran Smalley, Kapaettu Satyamoorthy, Gang Li, Meenhard Herlyn, The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma Frontiers in Bioscience. ,vol. 10, pp. 2986- 3001 ,(2005) , 10.2741/1755
N. T. Redpath, E. J. Foulstone, C. G. Proud, Regulation of translation elongation factor‐2 by insulin via a rapamycin‐sensitive signalling pathway. The EMBO Journal. ,vol. 15, pp. 2291- 2297 ,(1996) , 10.1002/J.1460-2075.1996.TB00582.X
Punita Dhawan, Ann Richmond, Amar B. Singh, Darrel L. Ellis, Constitutive Activation of Akt/Protein Kinase B in Melanoma Leads to Up-Regulation of Nuclear Factor-κB and Tumor Progression Cancer Research. ,vol. 62, pp. 7335- 7342 ,(2002)
H Glantschnig, J E Fisher, G Wesolowski, G A Rodan, A A Reszka, M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase Cell Death & Differentiation. ,vol. 10, pp. 1165- 1177 ,(2003) , 10.1038/SJ.CDD.4401285
Michael B. Dilling, Glen S. Germain, Randall K. Johnson, David N. Shapiro, Peter Dias, Peter J. Houghton, Rapamycin Selectively Inhibits the Growth of Childhood Rhabdomyosarcoma Cells through Inhibition of Signaling via the Type I Insulin-like Growth Factor Receptor Cancer Research. ,vol. 54, pp. 903- 907 ,(1994)
H. van der Poel, C. Hanrahan, H. Zhong, J. Simons, Rapamycin induces Smad activity in prostate cancer cell lines. Urological Research. ,vol. 30, pp. 380- 386 ,(2003) , 10.1007/S00240-002-0282-1
Peter Houghton, Targeting the IGF-1/mTOR pathway Clinical Cancer Research. ,vol. 14, ,(2008)
Richard C. Hresko, Mike Mueckler, mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes Journal of Biological Chemistry. ,vol. 280, pp. 40406- 40416 ,(2005) , 10.1074/JBC.M508361200